Specific and Shared Mechanisms Associated With Treatment for Chronic Neck Pain (SS-MECH)

November 17, 2025 updated by: Duke University

Specific and Shared Mechanisms Associated With Physical Therapy Interventions

It is expected that different physical therapy treatments influence outcomes in many different ways. Each treatment is assumed to have a "specific" treatment mechanism, which explains how that specific treatment works. Different treatments also have "shared" mechanisms, which are similar across many different types of interventions (e.g., exercise, cognitive treatments or manual therapy). In this study, the study team will investigate the several types of specific treatment mechanisms of a manual therapy-based approach and an exercise-based approach and the study team will compare these to see if they are different. The patient population will include individuals with chronic neck pain, which is a condition that leads to notable disability and pain. The study team will also evaluate several shared treatment mechanisms to see if these are similar across the two treatments (e.g., manual therapy versus exercise). The study team expects to find that there are some specific treatment mechanisms with each approach (manual therapy versus exercise) but also several "shared" mechanisms that are similar across the two seemingly different approaches. These will likely influence the outcomes and may help explain why clinicians see similar outcomes across both treatment groups for chronic neck pain. This study is important because no one has investigated whether the outcomes that occur with chronic neck pain are mostly influenced by specific or shared treatment mechanisms. Interestingly, in the psychological literature, shared treatment mechanisms demonstrate the strongest influence (more than specific treatment mechanisms).

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Treatment mechanisms involve the steps or processes through which an intervention unfolds and produces the change in an outcome variable. In other words, a treatment mechanism is "how a treatment works". Treatment mechanisms can be specific to the intervention provided (i.e., fiber size increase and neuro adaptation occur with resistance exercise) or shared with other treatments (i.e., theoretically, increased therapeutic alliance and reduced fear of movement occur with almost all forms of interventions). In this proposal, the study team plans to investigate specific and shared treatment mechanisms of a manual therapy approach and a resistance exercise approach for treatment of chronic neck pain. The study team is targeting chronic neck pain because it is a common problem that is second only to low back pain for years lived with disability. Routinely, chronic neck pain management includes manual therapy and resistance exercise, as both approaches are included in clinical practice guidelines. The study plans to answer two research questions: 1) what are the specific mechanisms associated with manual therapy and resistance exercise interventions (and are these different), and 2) what are the shared mechanisms associated with these interventions, and do both mechanisms mediate clinical outcomes? The study team hypothesized that manual therapy and resistance exercise approaches will exhibit different specific treatment mechanisms. Further, the team hypothesizes that both approaches will lead to shared treatment mechanisms, which will notably influence outcomes at both 4 weeks and 6-month follow-up. This study is important because it will help identify how different treatment mechanisms influence clinical outcomes. There are several studies in the psychological literature that demonstrate the role of both specific and shared treatment mechanisms but this form of investigation is mostly absent for general musculoskeletal rehabilitation interventions. It will be the first study involving manual therapy in which specific and shared mechanisms are evaluated and explored against clinical outcomes.

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29424
        • The Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Individuals with chronic neck pain (chronic pain is defined using the International Association of the Study of Pain (IASP) pragmatic criteria of pain lasting for 3 months or more that cannot be attributed to another diagnosis or condition.)
  • 18 years of age and older
  • experience ongoing neck pain of ≥3 on a 10-point scale for most days of the previous 3-months.

Exclusion Criteria:

  • Individuals with cervical pain and suspected radicular symptoms
  • a history of neck surgery within 1 year
  • current or suspected red flags
  • unable to speak or write in English.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Manual therapy treatment
Manual therapy treatments will consist of global soft tissue stretching of the upper trapezius, occipital muscles, levator scapula, and scalene muscles as the patient lies in supine. Non-thrust manipulation will consist of unilateral or central posterior-anterior accessory movements (PAIVMs) to the cervical and upper thoracic segments (in prone) at the most symptomatic levels. Passive physiological intervertebral movements of rotation will be performed in supine, as a mechanism to reduce pain and increase range of motion. Individuals with chronic neck pain randomized to the manual therapy arm, will be assigned a HEP twice daily that will consist of cervical rotations with belt or equivalent, side flexion with belt or equivalent, self-stretching exercises that are designed to target the upper thoracic musculature, and corner wall stretches.
Hands on treatments including manipulation, mobilization and soft-tissue mobilization with therapeutic intent.
Other Names:
  • Force based manipulations
Active Comparator: Resisted exercise treatment
In-clinic exercises will consist of chin retractions in sitting, supine clock isometric resistance, supine anterior neck flexion exercises that target the deep neck flexors, prone neck extensor exercises (with concurrent chin retraction), and lateral neck raises (bilaterally). The study team will also target the mid and upper thoracic region by performing upright rows, supine chest raises that target the mid-scapular muscles and the paraspinal muscles, prone "I, T, and Y" exercises, and proprioceptive neuromuscular facilitation exercises using a bar or a cane. Individuals randomized to the resistance exercise arm will be assigned a HEP twice daily that will consist of chin retractions in sitting, supine anterior neck flexion exercises, and elastic band rows that replicate the upright rows performed in the clinic.
Hands on treatments including manipulation, mobilization and soft-tissue mobilization with therapeutic intent.
Other Names:
  • Force based manipulations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Changes in Cervical Range of motion device (CROM) in flexion using a CROM
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in Cervical Range of motion device in extension using a CROM
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in Cervical Range of motion device rotation using a CROM
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in Cervical Range of motion device in side flexion using a CROM
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in Pain Pressure Threshold with Algometry
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in time held with the Deep Neck Flexor Endurance Test
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in in time held with the Cervical Extensor Endurance Test
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in in time held with the Lateral Neck Flexor Endurance Test for left side
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks
Changes in in time held with the Lateral Neck Flexor Endurance Test for right side
Time Frame: Baseline, 2 weeks, and 3 weeks
Baseline, 2 weeks, and 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Working Alliance Inventory (WAI).
Time Frame: Baseline, 2 weeks and 3 weeks
The WAI evaluates the collaborative relationship between the helper and the client, but does not encompass all aspects of the therapy relationship (i.e. clinical outcomes, recidivism).The WAI is a 36 item scale with 3 domains (task, goal and bond). Each item is scored 1 to 7, with higher scores reflecting better alliance with the therapist. Total scores range from 36 (low alliance) to 252 (higher alliance). Higher scores are better.
Baseline, 2 weeks and 3 weeks
Change in the the OSPRO-YF-10
Time Frame: Baseline, 2 weeks and 3 weeks
The OSPRO-YF is a 10 item Optimal Screening for Prediction of Referral and Outcome cohort yellow flag assessment tool. As OSPRO-YF summarizes 11 psychological questionnaires, it is not scored like a conventional screening tool. Quartile scores are used instead of cutoff scores for consistency and assessment of a wide range of outpatient orthopedic patients. Scores that are in the top quartile (top 25%) for negative psychological questionnaires (Negative Mood and Fear Avoidance questionnaires). Scores that are in the bottom quartile (bottom 25%) for positive psychological questionnaires (Positive Affect/Coping questionnaires).
Baseline, 2 weeks and 3 weeks
Change in the University of Washington Pain-Related Self Efficacy Scale short form
Time Frame: Baseline, 2 weeks and 3 weeks
The UW Pain Related Self-Efficacy Scale is intended for measuring disability management self-efficacy in adults with chronic health conditions. The 6 items on the short form are summed using the values provided for each response available in the clinician/researcher version of the form. This will give a summary score that ranges from 6 to 30. Using the Summary Score to T-score Conversion Table, we will use the summary score to look up the IRT-based T-score in the column labeled "Tscore" in the conversion table (page 7 below). This T-score is the final score we will use for all analyses.
Baseline, 2 weeks and 3 weeks
Change in Patient Health Engagement Scale
Time Frame: Baseline, 2 weeks and 3 weeks
The Patient Health Engagement Scale (PHE-s) is a patient self-administrable short psycho-metric questionnaire developed with the aim of diagnosing the level of patient engagement in their healthcare process that is function of his/her degree of emotional elaboration of the health condition. The scale has six items and each item is scored 1 to 7. A low score is poorer engagement whereas a higher score reflects higher engagement. Scores range from six to 42.
Baseline, 2 weeks and 3 weeks
Change in the PROMIS 29.2.
Time Frame: Baseline, 4 weeks, and 6 months
The PROMIS-29 v2.0 profile assesses pain intensity using a single 0-10 numeric rating item and seven health domains (physical function, fatigue, pain interference, depressive symptoms, anxiety, ability to participate in social roles and activities, and sleep disturbance) using four items per domain. Pain intensity is measured 0 to 10, with higher scores reflecting more pain. The other scales are measured as a t score, where 50% reflects the norm and value lower or higher reflect the current scoring by standard deviation to the general population.
Baseline, 4 weeks, and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Chad E Cook, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2024

Primary Completion (Actual)

April 30, 2025

Study Completion (Actual)

October 22, 2025

Study Registration Dates

First Submitted

May 26, 2023

First Submitted That Met QC Criteria

July 3, 2023

First Posted (Actual)

July 11, 2023

Study Record Updates

Last Update Posted (Actual)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 17, 2025

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The proposal will follow the data sharing guidelines set forth for the NIH HEAL Initiative®. As with the HEAL initiative, we plan to create an infrastructure that addresses the need for researchers, clinicians, and patients to collaborate on sharing their collective data. Our Data Sharing Plan that (1) will make the two projected Publications Open Access and, to the extent possible, and (2) will make the Underlying Primary Data immediately and broadly available to the public. Underlying Primary Data should be made as widely and freely available as possible while safeguarding the privacy of participants and protecting confidential and proprietary data.

IPD Sharing Time Frame

Protocol when published. SAP within the protocol when published. Informed consent once approval of IRB.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe